Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH)

Market Open
21 Jul, 14:47
NYSE NYSE
$
279. 34
-2.14
-0.7603%
$
22.61B Market Cap
- P/E Ratio
2.47% Div Yield
93,372 Volume
- Eps
$ 281.48
Previous Close
Add Transaction
Day Range
277.04 281.67
Year Range
244.52 293.72
Want to track LH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings

LabCorp Analysts Boost Their Forecasts After Better-Than-Expected Earnings

Labcorp Holdings Inc LH reported better-than-expected second-quarter financial results and raised its FY24 revenue guidance above estimates on Thursday.

Benzinga | 1 year ago
Labcorp (LH) Q2 Earnings Surpass Estimates (revised)

Labcorp (LH) Q2 Earnings Surpass Estimates (revised)

Labcorp (LH) beats on earnings and revenues in the second quarter, entering the second half of 2024 with robust momentum.

Zacks | 1 year ago
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector

LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector

Thursday, Laboratory Corp A reported second-quarter 2024 adjusted EPS of $3.94, up from $3.42 a year ago, beating the consensus of $3.78.

Benzinga | 1 year ago
Labcorp (LH) Q2 Earnings Surpass Estimates, Margins Increase

Labcorp (LH) Q2 Earnings Surpass Estimates, Margins Increase

Labcorp (LH) beats on earnings and revenues in the second quarter, entering the second half of 2024 with robust momentum.

Zacks | 1 year ago
Compared to Estimates, Labcorp (LH) Q2 Earnings: A Look at Key Metrics

Compared to Estimates, Labcorp (LH) Q2 Earnings: A Look at Key Metrics

The headline numbers for Labcorp (LH) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 1 year ago
Labcorp (LH) Beats Q2 Earnings and Revenue Estimates

Labcorp (LH) Beats Q2 Earnings and Revenue Estimates

Labcorp (LH) came out with quarterly earnings of $3.94 per share, beating the Zacks Consensus Estimate of $3.78 per share. This compares to earnings of $3.42 per share a year ago.

Zacks | 1 year ago
Labcorp beats Q2 profit and revenue estimates on demand for health tests

Labcorp beats Q2 profit and revenue estimates on demand for health tests

Labcorp beat Wall Street expectations for second-quarter profit and revenue on Thursday on strong demand for its diagnostic tests, and raised its sales growth forecast for the year.

Reuters | 1 year ago
Labcorp (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Labcorp (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Labcorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
Here's How Labcorp (LH) is Placed Ahead of Q2 Earnings Release

Here's How Labcorp (LH) is Placed Ahead of Q2 Earnings Release

Labcorp's (LH) second-quarter 2024 performance is expected to reflect the robust execution of strategic priorities and solid business performances.

Zacks | 1 year ago
Here's Why Labcorp (LH) is a Strong Value Stock

Here's Why Labcorp (LH) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 years ago
Is It the Right Time to Hold Labcorp (LH) in Your Portfolio?

Is It the Right Time to Hold Labcorp (LH) in Your Portfolio?

Labcorp's (LH) concentrated development in high-growth areas and strategic partnerships appear encouraging.

Zacks | 2 years ago
Why Labcorp (LH) is a Top Value Stock for the Long-Term

Why Labcorp (LH) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 2 years ago
Loading...
Load More